Frequently Asked Questions
Factors such as surge in abortion rate and rising childbirth using labor induction are acting as the major drivers for the global uterotonic agent market.
Nexus Pharmaceuticals (U.S.), Pfizer Inc (U.S.), Dr. Reddy's Laboratories Ltd (India), Corcept (U.S.), GenBioPro (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Amneal Pharmaceuticals Inc (U.S.), Lupin (India) , Daiichi Sankyo Company Limited (Japan), and Ferring B.V. (Switzerland).
The Uterotonic Agent Market segments covered in this report are By Drug (Carboprost, Mifepristone, Methylergonovine, Dinoprostone, Dinoprostone, Others), Indication (Postpartum Hemorrhage, Abortion, Labor, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy).
